Venture Capital Archives - Page 102 of 106

Perceptive Imaging Names Doug Fulling as CEO to Lead Next Phase of Growth and Innovation

October 9, 2025

Affinia Therapeutics Raises $40 Million Series C to Advance Next-Generation Gene Therapies for Cardiovascular and Neurological Diseases

October 7, 2025

RevBio Awarded $2.2 Million NIH Grant to Advance Minimally Invasive Use of TETRANITE® for Treating Spine Fractures

October 6, 2025

THIS WEEK'S STORIES

Precision BioSciences Opens First U.S. Clinical Trial Site for ELIMINATE-B Study at Massachusetts General Hospital

October 7, 2025

Alloy Therapeutics and University of British Columbia Partner to Advance Antibody Discovery Using Cryo-Electron Microscopy

October 7, 2025

Perceptive Imaging Names Doug Fulling as CEO to Lead Next Phase of Growth and Innovation

October 9, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Venture Capital

Bristol Myers Squibb Expands Cell Therapy Capabilities with $1.5 Billion Acquisition of Orbital Therapeutics

Expedition Therapeutics Raises $165 Million in Oversubscribed Series A to Advance First-in-Class COPD Therapy

Jefferson River Capital Launches Jefferson Life Sciences, a New Early-Stage Investment Firm Focused on Human Health Innovation

Adicet Bio Announces $80 Million Registered Direct Offering

Affinia Therapeutics Raises $40 Million Series C to Advance Next-Generation Gene Therapies for Cardiovascular and Neurological Diseases

Most Read

Bristol Myers Squibb and TV Host Gail Simmons Launch Initiative to Reduce Stigma and Build Support for People Living with Schizophrenia

Urban Green Council Honors Suffolk Chairman and CEO John Fish for Leadership in Sustainable Building

Pulse Biosciences Reports Positive First-in-Human Results for nPulse Cardiac Surgical System at European Cardio-Thoracic Surgery Meeting

Tilak Healthcare Secures Reimbursement for Odysight, the First Remote Ophthalmology Monitoring Solution, Under France’s PECAN Program

EDITOR PICKS

Perceptive Imaging Names Doug Fulling as CEO to Lead Next Phase of Growth and Innovation

Affinia Therapeutics Raises $40 Million Series C to Advance Next-Generation Gene Therapies for Cardiovascular and Neurological Diseases

RevBio Awarded $2.2 Million NIH Grant to Advance Minimally Invasive Use of TETRANITE® for Treating Spine Fractures

THIS WEEK'S STORIES

Precision BioSciences Opens First U.S. Clinical Trial Site for ELIMINATE-B Study at Massachusetts General Hospital

Alloy Therapeutics and University of British Columbia Partner to Advance Antibody Discovery Using Cryo-Electron Microscopy

Perceptive Imaging Names Doug Fulling as CEO to Lead Next Phase of Growth and Innovation

POPULAR CATEGORY

ABOUT US

FOLLOW US